Evidence map›Paper›PMID 42171792›Full record

ArticleNeurosurgical review2026

Mid- to long-term outcomes of different treatment strategies for chronic carotid artery occlusion: a single-center cohort study.

Qihang Zhang, Tongyu Yang, Lei Li, Huan Zhu, Chenyu Zhu, Tong Liu, Xingju Liu, Qian Zhang, Feng Gao, Yan Zhang and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Neurosurgical review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Qihang ZhangDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing Neurosurgical Institute, Beijing, China.
Tongyu YangDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing Neurosurgical Institute, Beijing, China.
Lei LiNeurology Department, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Huan ZhuDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing Neurosurgical Institute, Beijing, China.
Chenyu ZhuDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing Neurosurgical Institute, Beijing, China.
Tong LiuDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing Neurosurgical Institute, Beijing, China.
Xingju LiuDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing Neurosurgical Institute, Beijing, China.
Qian ZhangDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing Neurosurgical Institute, Beijing, China.
Feng GaoNeurology Department, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Yan ZhangDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing Neurosurgical Institute, Beijing, China. yanzhang166@163.com.
Yunna YangDepartment of Neurosurgery, Beijing Chao-yang Hospital, Capital Medical University, Beijing, China. yangyyn2015@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic internal carotid artery occlusion (CICAO) is a significant cause of ischemic cerebrovascular events, with an annual stroke risk of up to 20%. Although the long-term efficacy of hybrid surgical revascularization (HSR) versus conservative medical therapy (CMT) remains controversial, preliminary studies suggest HSR may improve cognitive function. This study aimed to evaluate the long-term efficacy and safety of HSR versus CMT in CICAO patients and explore prognostic factors. A retrospective analysis included 62 CICAO patients (37 HSR, 25 CMT) from Beijing Tiantan Hospital (2016-2019), with a mean follow-up of 81 months. The HSR group underwent carotid endarterectomy combined with endovascular therapy, while the CMT group received standardized antiplatelet and lipid-lowering therapy. The primary endpoint was recurrent cerebral infarction, and the secondary endpoint was mortality. Kaplan-Meier survival analysis and multivariable Cox regression models were used for exploratory efficacy assessment. Given the limited sample size and the non-randomized treatment allocation, propensity score matching was not performed; instead, treatment allocation and baseline imbalance were explicitly described and the findings were interpreted with caution. The HSR group showed a lower annual recurrent infarction rate than the CMT group (3.6% vs. 7.6%, p = 0.025), whereas the apparent mortality difference was not supported by adjusted analysis because no death events occurred in the HSR group and the mortality model was unstable. Subgroup analysis showed heterogeneity according to angiographic recanalization status. In survival analysis, HSR was associated with a numerically lower risk of recurrent infarction, but the association did not reach statistical significance after adjustment (adjusted HR 0.49, p = 0.16). In this single-center retrospective cohort, HSR was associated with a lower crude rate of recurrent cerebral infarction during long-term follow-up, but the adjusted analyses did not confirm a statistically robust reduction in recurrent infarction or mortality. These findings should therefore be interpreted as hypothesis-generating. Hemodynamic improvement rather than complete anatomical recanalization may be relevant to outcome, and larger prospective studies are required for confirmation.

Indexed as

Carotid Artery, InternalCarotid StenosisAgedCerebral InfarctionChronic DiseaseConservative TreatmentEndarterectomy, CarotidEndovascular ProceduresFemaleFollow-Up StudiesHumansMaleRetrospective StudiesTreatment OutcomeChronic Internal Carotid Artery OcclusionConservative Medical TherapyHybrid Surgical RevascularizationRecanalizationRecurrent Infarction

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.